Biobetter Bo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biobetter bo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biobetter Bo Today - Breaking & Trending Today
Press release content from Globe Newswire. The AP news staff was not involved in its creation. CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) . CytoDel IncJanuary 7, 2021 GMT Studies Show Cyto-111 Enables Delivery of Antibodies to Previously Inaccessible Intraneuronal Targets without the need for a Viral Vector or Transfection Supports the Development of New Approaches to Treat Multiple Neurological Diseases NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) CytoDel, Inc. (“CytoDel” or “the Company”), a privately-held corporation, today announces the publication of preclinical data on the Company’s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. The complete text of the article titled, “Neuronal Delivery of Antibodies has Therapeutic Effects in Animal Models of Botulism,” can be found here. ....
E-Mail New York City, January 6, 2021 - CytoDel, Inc. ( CytoDel or the Company ), a privately-held corporation, today announces the publication of preclinical data on the Company s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. The complete text of the article titled, Neuronal Delivery of Antibodies has Therapeutic Effects in Animal Models of Botulism, can be found here. Cyto-111 was conceived, expressed and purified in the laboratory of Konstantin Ichtchenko, Ph.D., NYU Grossman School of Medicine, Department of Biochemistry and Molecular Pharmacology, who was a principal investigator in the study, which was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institute of Health (NIH). ....